Replimune Group, Inc. (REPL)
2.50
-0.07
(-2.72%)
USD |
NASDAQ |
May 01, 16:00
2.49
-0.01
(-0.40%)
After-Hours: 20:00
Replimune Group Price : 2.50 for May 1, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 80.39 |
| Bristol Myers Squibb Co. | 58.22 |
| Phathom Pharmaceuticals, Inc. | 12.01 |
| REGENXBIO, Inc. | 9.12 |
| Catalyst Pharmaceuticals, Inc. | 28.74 |
Price Related Metrics
| PEG Ratio | -0.05 |
| Price to Book Value | 0.9805 |
| Earnings Yield | -143.3% |
| Market Cap | 206.43M |
| PEGY Ratio | -0.05 |